Background and Objective: Diabetes mellitus imposes a substantial burden on male fertility, adversely affecting sperm quality through structural damage in the reproductive tract, endocrine disruption, and dysregulation of cellular metabolism. While glucose-lowering agents help achieve glycemic control, they may also ameliorate diabetes-induced impairment of sperm quality. However, these drugs exert heterogeneous effects on male reproduction via divergent mechanisms, with outcomes often varying between in vivo and in vitro settings. This review aims to systematically evaluate the impacts of different antihyperglycemic therapies on semen quality and elucidate their mechanistic bases, to guide therapy selection for improving fertility in diabetic men. Methods: A comprehensive search of the PubMed and Embase databases was conducted, covering the period from their inception to 2025. Key Content and Findings: Insulin enhances sperm DNA integrity via Hsp70-2/TP-1/TP-2 upregulation and acts as a cryoprotectant. Metformin activates AMPK-mediated autophagy and synergizes with zinc to preserve fertility. SGLT-2 inhibitors suppress testicular apoptosis via Nrf2/HO-1 antioxidant pathways. Critically, sulfonylureas improve in vivo sperm quality but exert spermicidal effects in vitro by disrupting calcium homeostasis. Conclusions: Current evidence supports the potential of certain antihyperglycemic agents in mitigating diabetes-related male infertility, though drug-specific and context-dependent effects must be considered. Further phenotype-targeted studies are needed to optimize clinical treatment strategies.
Recurrent miscarriage (RM), a complex pregnancy disorder with largely undefined molecular mechanisms, has been associated with epigenetic abnormalities in chorionic tissue. This study aimed to elucidate methylation-dependent cilia-related genes (CRGs) implicated in RM. An integrative analysis combining RNA sequencing, public transcriptome data, and DNA methylation profiles was conducted to identify RM-related CRGs. Machine learning algorithms were applied to determine the most relevant candidates. Immune infiltration profiling, gene set enrichment analysis (GSEA), and competitive endogenous RNA (ceRNA) network construction were employed to clarify molecular pathways. RT-qPCR validation was performed using clinical samples. Fourteen methylation-regulated CRGs were identified, among which SLC1A2 and ZDHHC20 were confirmed as key candidates. GSEA indicated their association with spliceosome, cell cycle, and proteasome pathways. Immune analysis demonstrated decreased infiltration of activated CD4 + T cells, effector memory CD4 + T cells, and Th2 cells in RM, with SLC1A2 and ZDHHC20 expression positively correlated with these immune subsets. The ceRNA networks indicated that SLC1A2 and ZDHHC20 were modulated by 7 miRNAs and 19 lncRNAs, respectively. RT-qPCR results showed significant overexpression of SLC1A2, but not ZDHHC20, in RM chorionic tissue. Collectively, SLC1A2 represents a methylation-regulated CRG that links ciliary impairment, immune imbalance, and epigenetic modulation in RM, revealing a novel molecular axis and suggesting its diagnostic and therapeutic potential.
28 November 2025 in European Journal of Pediatrics